As shown in (Fig 1A), our analysis showed that the overexpression of IL-13α2 in ACC tumors is associated with a lower patient survival time compared to low expression of IL-13Rα2 (p = 0.0112) (Fig 1B). The gene discussed is IL13RA2; the disease is adrenal cortex carcinoma.